Maternal Hypotension During Cesarean Section and Short Term Neonatal Outcome.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00330512|
Recruitment Status : Terminated
First Posted : May 26, 2006
Last Update Posted : June 30, 2009
About 20-25% of deliveries are by cesarean section. Most are elective with use of regional anesthesia (spinal/epidural). Drop of blood pressure after regional anesthesia is common. It have the risk of reduction of blood flow to the placenta and the fetus.
No studies had followed the newborns their first days of live,of mothers who developed hypotension in durins CS.
|Condition or disease|
|Elective Cesarean Section Maternal Hypotention|
A reterospective study of all full term babies, born in elective cesarean section with use of regional anesthesia. Two groups will be define rgarding maternal hypotention following regional anesthesia - maternal hypotention (study group) or normal maternal BP. The definition of Maternal hypotension: decrease in 10% or more in mean BP in compared to first BP taken at admition.
Data will colect from mothers and neonates records as well as operation data. Maternal data: gravida, parity, diseases, medications, demographics, and all data regarding the operation (blood pressures, Heart rates, saturation, treatment given etc.).
Infant data: gestational age, birth weight, sex, Apgar, cord pH, clinical manifestations, medications, time of hospitalization.
|Study Type :||Observational|
|Estimated Enrollment :||500 participants|
|Official Title:||Maternal Hypotension During Elective Cesarean Section and Short Term Neonatal Outcome.|
|Study Start Date :||May 2006|
|Actual Primary Completion Date :||July 2007|
|Actual Study Completion Date :||July 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00330512
|Principal Investigator:||Ayala Maayan, MD||Sheba Medical Center|